******************************************************
5.
Furosemiade
" Lasix " :
Trade names: Apo-Furosemide,
Lasix
Drug class: Loop diuretics
Pregnancy:
(Category C/ D if used in pregnancy-induced hypertension.]
Therapeutic actions
§
Inhibits the reabsorption of
sodium and chloride from the proximal and distal renal tubules and the loop of
Henle, leading to a sodium-rich diuresis.
Indications
·
Edema associated with CHF,
cirrhosis, renal disease (oral, IV)
·
Acute pulmonary edema (IV)
·
Hypertension (oral)
Contraindications/cautions
·
Contraindications:
allergy to furosemide, sulfonamides; allergy to tartrazine (in oral solution);
electrolyte depletion; anuria, severe renal failure; hepatic coma; pregnancy;
lactation.
·
Use
cautiously with SLE, gout, diabetes mellitus.
Dose
§
by mouth,
oedema, initially 40 mg in the morning; maintenance 20–40 mg daily,
increased in resistant oedema to 80 mg daily or more;
§
CHILD 1–3 mg/kg
daily, max. 40 mg daily
Oliguria, initially 250 mg daily; if necessary larger doses, increasing in steps of 250 mg, may be given every 4–6 hours to a max. Of a single dose of 2 g (rarely used)
Oliguria, initially 250 mg daily; if necessary larger doses, increasing in steps of 250 mg, may be given every 4–6 hours to a max. Of a single dose of 2 g (rarely used)
§
By
intramuscular injection or slow intravenous injection, initially
20–50 mg; CHILD 0.5–1.5 mg/kg to a max. daily dose of 20 mg
§
By
intravenous infusion (by syringe pump if necessary), in oliguria,
initially 250 mg over 1 hour (rate not exceeding 4 mg/minute), if
satisfactory urine output not obtained in the subsequent hour further
500 mg over 2 hours, then if no satisfactory response within subsequent
hour, further 1 g
over 4 hours, if no response obtained dialysis probably required; effective
dose (up to 1 g)
can be repeated every 24 hours
Adverse effects
- CNS: Dizziness, vertigo, paresthesias, xanthopsia, weakness, headache, drowsiness, fatigue, blurred vision, tinnitus, irreversible hearing loss
- GI: Nausea, anorexia, vomiting, oral and gastric irritation, constipation, diarrhea, acute pancreatitis, jaundice
- CV: Orthostatic hypotension, volume depletion, cardiac arrhythmias, thrombophlebitis
- Hematologic: Leukopenia, anemia, thrombocytopenia, fluid and electrolyte imbalances
- GU: Polyuria, nocturia, glycosuria, urinary bladder spasm
- Dermatologic: Photosensitivity, rash, pruritus, urticaria, purpura, exfoliative dermatitis, erythema multiforme
- Other: Muscle cramps and muscle spasms
Clinically
important interactions
- Drug-drug
- Increased risk of cardiac arrhythmias with digitalis glycosides (due to electrolyte imbalance)
- Increased risk of ototoxicity with aminoglycoside antibiotics, cisplatin
- Decreased absorption of furosemide with phenytoin
- Decreased natriuretic and antihypertensive effects with indomethacin, ibuprofen, other NSAIDs
- Decreased GI absorption with charcoal
Nursing Considerations
- Administer with food or milk to prevent GI upset.
- Reduce dosage if given with other antihypertensive; readjust dosages gradually as BP responds.
- Give early in the day so that increased urination will not disturb sleep.
- Avoid IV use if oral use is at all possible.
- Do not mix parenteral solution with highly acidic solutions with pH below 3.5.
- Do not expose to light, may discolor tablets or solution; do not use discolored drug or solutions.
- Discard diluted solution after 24 h.
- Refrigerate oral solution.
- Measure and record weight to monitor fluid changes.
- Arrange to monitor serum electrolytes, hydration, and liver function.
- Arrange for potassium-rich diet or supplemental potassium as needed.
*******************************************************
6.
Gentamycin
:
Trade name: Garamyein.
Class: - antibiotic, aminoglycoside.
Pregnancy:
(Category C)
Indication:
v
It is
the drug of choice for hospital- acquired gram negative
sepsis including neonatal sepsis.
v
Serious staphylococcal
infections.
Side
effects
§
blood pressure, alopecia
§
CNS: ototoxicity, tinnitus, dizziness, ringing in the ears, vertigo.
§
GI: nausea, vomiting, anorexia, weight loss, increased
salivation.
§
C.V.: palpitation, hypotension or hypertension.
§
Hematologic: Decrease number of blood cells.
§
GU: nephrotoxicity
§
Local: Pain and irritation at IM injection site.
Formulation:-
Vial 2 ml
containing 20 mg.
Ampoule 2 ml
containing 80 mg.
Dosage:-
v
I.M. (usual). I.V. adults 3 mg\kg q 8 hr up to
5 mg\kg daily.
Children
2-2.5 mg\kg q 8 hr.
Newborns
2.5 mg\ kg q 12 hr.
Ophthalmic
solution 0.3%, 1-2 drops q 15-30 minutes.
Topical
ointment 0.1%, 1-5 times daily to the affected area.
Streptococcal or enterococcal endocarditis in
combination with other drugs, 80 mg twice daily.
N.B.:-
Should not be mixed with other drugs for
parenteral use.
Nursing implication:
§
When given
IM, give it slowly and deep in the muscle.
§
Dilute
dose when given IV.
§
Monitor
for kidney function tests, complete blood count when used for more than 7 days.
Consult with Dr. accordingly.
*******************************************************
ليست هناك تعليقات:
إرسال تعليق